United Therapeutics Corporation (UTHR) Insider Trading
- $999,400.80
- $834,836,763.10
- April 17, 2025
- Martine A Rothblatt
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Nov. 19, 2014 | CEO | 2,211 | $128.69 | Sell | $284,533.59 | |
Nov. 18, 2014 | COO | 10,000 | $128.21 | Sell | $1,282,100.00 | |
Nov. 17, 2014 | CEO | 2,592 | $125.65 | Sell | $325,684.80 | |
Nov. 13, 2014 | CEO | 9,662 | $124.79 | Sell | $1,205,720.98 | |
Nov. 12, 2014 | CEO | 2,211 | $122.88 | Sell | $271,687.68 | |
Nov. 10, 2014 | CEO | 2,592 | $125.14 | Sell | $324,362.88 | |
Nov. 7, 2014 | Director | 5,000 | $124.49 | Sell | $622,450.00 | |
Nov. 7, 2014 | COO | 10,000 | $124.46 | Sell | $1,244,600.00 | |
Nov. 6, 2014 | EVP | 5,000 | $125.02 | Sell | $625,100.00 | |
Nov. 6, 2014 | Director | 1,500 | $122.89 | Sell | $184,335.00 | |
Nov. 6, 2014 | CEO | 4,115 | $125.33 | Sell | $515,732.95 | |
Nov. 5, 2014 | CEO | 2,211 | $124.31 | Sell | $274,849.41 | |
Nov. 3, 2014 | CEO | 2,592 | $127.49 | Sell | $330,454.08 | |
Oct. 30, 2014 | CEO | 9,662 | $130.42 | Sell | $1,260,118.04 | |
Oct. 29, 2014 | CEO | 2,211 | $131.10 | Sell | $289,862.10 | |
Oct. 27, 2014 | CEO | 2,592 | $132.16 | Sell | $342,558.72 | |
Oct. 23, 2014 | CEO | 11,873 | $129.97 | Sell | $1,543,133.81 | |
Oct. 23, 2014 | EVP | 11,000 | $127.04 | Sell | $1,397,440.00 | |
Oct. 13, 2014 | CEO | 2,592 | $124.31 | Sell | $322,211.52 | |
Oct. 9, 2014 | EVP | 5,000 | $130.59 | Sell | $652,950.00 | |
Oct. 9, 2014 | CEO | 9,662 | $129.97 | Sell | $1,255,770.14 | |
Oct. 8, 2014 | CEO | 2,211 | $131.50 | Sell | $290,746.50 | |
Oct. 7, 2014 | COO | 35,000 | $130.14 | Sell | $4,554,900.00 | |
Oct. 6, 2014 | CEO | 2,592 | $129.32 | Sell | $335,197.44 | |
Oct. 3, 2014 | COO | 10,000 | $129.79 | Sell | $1,297,900.00 | |
Oct. 2, 2014 | CFO | 10,000 | $129.46 | Sell | $1,294,600.00 | |
Oct. 2, 2014 | EVP | 6,000 | $129.46 | Sell | $776,760.00 | |
Oct. 2, 2014 | Director | 1,500 | $130.65 | Sell | $195,975.00 | |
Oct. 2, 2014 | CEO | 9,662 | $127.72 | Sell | $1,234,030.64 | |
Oct. 1, 2014 | CEO | 2,211 | $127.40 | Sell | $281,681.40 | |
Sept. 30, 2014 | COO | 20,000 | $128.65 | Sell | $2,573,000.00 | |
Sept. 25, 2014 | CEO | 5,547 | $134.26 | Sell | $744,740.22 | |
Sept. 25, 2014 | Director | 20,000 | $134.94 | Sell | $2,698,800.00 | |
Sept. 25, 2014 | EVP | 5,000 | $133.77 | Sell | $668,850.00 | |
Sept. 23, 2014 | COO | 50,000 | $131.02 | Sell | $6,551,000.00 | |
Sept. 19, 2014 | COO | 10,000 | $129.60 | Sell | $1,296,000.00 | |
Sept. 18, 2014 | CEO | 9,662 | $127.35 | Sell | $1,230,455.70 | |
Sept. 18, 2014 | EVP | 6,000 | $130.93 | Sell | $785,580.00 | |
Sept. 18, 2014 | CFO | 10,000 | $130.93 | Sell | $1,309,300.00 | |
Sept. 17, 2014 | COO | 20,000 | $127.01 | Sell | $2,540,200.00 | |
Sept. 15, 2014 | CEO | 50,000 | $124.52 | Sell | $6,226,000.00 | |
Sept. 11, 2014 | EVP | 5,000 | $120.70 | Sell | $603,500.00 | |
Sept. 11, 2014 | CEO | 9,662 | $120.79 | Sell | $1,167,072.98 | |
Sept. 10, 2014 | CEO | 50,000 | $120.01 | Sell | $6,000,500.00 | |
Sept. 10, 2014 | Director | 20,000 | $119.95 | Sell | $2,399,000.00 | |
Sept. 5, 2014 | COO | 10,000 | $111.29 | Sell | $1,112,900.00 | |
Sept. 4, 2014 | CFO | 10,000 | $112.38 | Sell | $1,123,800.00 | |
Sept. 4, 2014 | Director | 3,000 | $113.40 | Sell | $340,200.00 | |
Sept. 4, 2014 | CEO | 9,662 | $112.87 | Sell | $1,090,549.94 | |
Sept. 4, 2014 | EVP | 6,000 | $112.38 | Sell | $674,280.00 |
Insiders are both buying and selling United Therapeutics Corporation stock.
The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, Raymond Dwek, John Maxim Ferrari, Christopher Patusky, Paul Mahon, David Zaccardelli, Michael Benkowitz, Richard Giltner, Nilda Mesa, James Edgemond, Louis W Sullivan, Tommy G Thompson, Judy D Olian, Ray Kurzweil, Paul A. Mahon, Judy D. Olian, R Paul Gray, MAHON PAUL A, Louis Sullivan, Tommy G. Thompson, and DWEK RAYMOND
The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 386 trades.
Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $372,318,923.20.
Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.
The most recent insider trade for United Therapeutics Corporation was on April 17, 2025.
The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.
The single biggest insider sell for United Therapeutics Corporation was from Louis W Sullivan with a total value of $9,781,722.98 on Dec. 18, 2024.